Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Immune Checkpoint Inhibitors market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.4% during the forecast period.
This report presents the market size and development trends by detailing the Immune Checkpoint Inhibitors market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Immune Checkpoint Inhibitors market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Immune Checkpoint Inhibitors industry and will help you to build a panoramic view of the industrial development.
Immune Checkpoint Inhibitors Market, By Type:
PD-1/PD-L1
CTLA-4
Immune Checkpoint Inhibitors Market, By Application:
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Melanoma
Blood Cancer
Other
Some of the leading players are as follows:
Immutep
Roche / Genentech
Bristol Myer Squibb
CureTech
Seattle Genetics
AstraZeneca
Merck & Co
Pfizer
Innate Pharma
Celldex Therapeutics
Sorrento Therapeutics
Incyte Corporation.
ArGEN-X
GITR, Inc
NewLink Genetics
MacroGenics
GlaxoSmithKline
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Immune Checkpoint Inhibitors Market: Technology Type Analysis
-
4.1 Immune Checkpoint Inhibitors Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Immune Checkpoint Inhibitors Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 PD-1/PD-L1
4.3.2 CTLA-4
5 Immune Checkpoint Inhibitors Market: Product Analysis
-
5.1 Immune Checkpoint Inhibitors Product Market Share Analysis, 2018 & 2026
-
5.2 Immune Checkpoint Inhibitors Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Immune Checkpoint Inhibitors Market: Application Analysis
-
6.1 Immune Checkpoint Inhibitors Application Market Share Analysis, 2018 & 2026
-
6.2 Immune Checkpoint Inhibitors Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Lung Cancer
6.3.2 Colorectal Cancer
6.3.3 Breast Cancer
6.3.4 Prostate Cancer
6.3.5 Melanoma
6.3.6 Blood Cancer
6.3.7 Other
7 Immune Checkpoint Inhibitors Market: Regional Analysis
-
7.1 Immune Checkpoint Inhibitors Regional Market Share Analysis, 2018 & 2026
-
7.2 Immune Checkpoint Inhibitors Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Immutep
9.1.1 Immutep Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Roche / Genentech
9.2.1 Roche / Genentech Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Bristol Myer Squibb
9.3.1 Bristol Myer Squibb Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 CureTech
9.4.1 CureTech Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Seattle Genetics
9.5.1 Seattle Genetics Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 AstraZeneca
9.6.1 AstraZeneca Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Merck & Co
9.7.1 Merck & Co Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Pfizer
9.8.1 Pfizer Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Innate Pharma
9.9.1 Innate Pharma Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Celldex Therapeutics
9.10.1 Celldex Therapeutics Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Sorrento Therapeutics
9.11.1 Sorrento Therapeutics Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Incyte Corporation.
9.12.1 Incyte Corporation. Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 ArGEN-X
9.13.1 ArGEN-X Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 GITR, Inc
9.14.1 GITR, Inc Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 NewLink Genetics
9.15.1 NewLink Genetics Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 MacroGenics
9.16.1 MacroGenics Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 GlaxoSmithKline
9.17.1 GlaxoSmithKline Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
The List of Tables and Figures (Totals 102 Figures and 145 Tables)
Figure PD-1/PD-L1 Immune Checkpoint Inhibitors market, 2015 - 2026 (USD Million)
Figure CTLA-4 Immune Checkpoint Inhibitors market, 2015 - 2026 (USD Million)
Figure Lung Cancer market, 2015 - 2026 (USD Million)
Figure Colorectal Cancer market, 2015 - 2026 (USD Million)
Figure Breast Cancer market, 2015 - 2026 (USD Million)
Figure Prostate Cancer market, 2015 - 2026 (USD Million)
Figure Melanoma market, 2015 - 2026 (USD Million)
Figure Blood Cancer market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Immune Checkpoint Inhibitors market, by country, 2015 - 2026 (USD Million)
-
Table North America Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table North America Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table North America Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Canada Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Canada Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Europe Immune Checkpoint Inhibitors market, by country, 2015 - 2026 (USD Million)
-
Table Europe Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Europe Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Europe Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Germany Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Germany Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table France Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table France Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Italy Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Italy Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Spain Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Spain Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immune Checkpoint Inhibitors market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table China Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table China Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Japan Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Japan Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table India Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table India Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Immune Checkpoint Inhibitors market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table MEA Immune Checkpoint Inhibitors market, by country, 2015 - 2026 (USD Million)
-
Table MEA Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table MEA Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table MEA Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Immune Checkpoint Inhibitors market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Immune Checkpoint Inhibitors market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Immune Checkpoint Inhibitors market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Immutep Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche / Genentech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bristol Myer Squibb Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CureTech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Seattle Genetics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Innate Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Celldex Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sorrento Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Incyte Corporation. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ArGEN-X Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GITR, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table NewLink Genetics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MacroGenics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
